HomeCompareSRGA vs CL

SRGA vs CL: Dividend Comparison 2026

SRGA yields 1093.49% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRGA wins by $41252575.60M in total portfolio value
10 years
SRGA
SRGA
● Live price
1093.49%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41252575.64M
Annual income
$34,962,891,590,796.23
Full SRGA calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — SRGA vs CL

📍 SRGA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRGACL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRGA + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRGA pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRGA
Annual income on $10K today (after 15% tax)
$92,946.97/yr
After 10yr DRIP, annual income (after tax)
$29,718,457,852,176.80/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, SRGA beats the other by $29,718,457,847,542.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRGA + CL for your $10,000?

SRGA: 50%CL: 50%
100% CL50/50100% SRGA
Portfolio after 10yr
$20626287.84M
Annual income
$17,481,445,798,123.97/yr
Blended yield
84.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

SRGA
No analyst data
Altman Z
-14.1
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRGA buys
0
CL buys
0
No recent congressional trades found for SRGA or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRGACL
Forward yield1093.49%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$41252575.64M$41.0K
Annual income after 10y$34,962,891,590,796.23$5,451.69
Total dividends collected$40777781.60M$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: SRGA vs CL ($10,000, DRIP)

YearSRGA PortfolioSRGA Income/yrCL PortfolioCL Income/yrGap
1← crossover$120,049$109,349.37$11,014$313.84+$109.0KSRGA
2$1,355,305$1,226,852.64$12,200$415.44+$1.34MSRGA
3$14,394,696$12,944,519.24$13,607$553.09+$14.38MSRGA
4$143,891,771$128,489,446.28$15,301$741.41+$143.88MSRGA
5$1,354,339,736$1,200,375,541.00$17,374$1,002.00+$1354.32MSRGA
6$12,008,197,800$10,559,054,282.68$19,958$1,367.44+$12008.18MSRGA
7$100,345,428,030$87,496,656,383.52$23,243$1,887.87+$100345.40MSRGA
8$790,694,806,514$683,325,198,522.44$27,512$2,642.43+$790694.78MSRGA
9$5,878,209,395,115$5,032,165,952,144.85$33,197$3,759.22+$5878209.36MSRGA
10$41,252,575,643,570$34,962,891,590,796.23$40,973$5,451.69+$41252575.60MSRGA

SRGA vs CL: Complete Analysis 2026

SRGAStock

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Full SRGA Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this SRGA vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRGA vs SCHDSRGA vs JEPISRGA vs OSRGA vs KOSRGA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.